Skip to main content
Top
Published in: Metabolic Brain Disease 4/2006

01-12-2006 | Original Paper

Investigation of oxidative stress parameters in treated phenylketonuric patients

Authors: A. Sitta, A. G. Barschak, M. Deon, T. Terroso, R. Pires, R. Giugliani, C. S. Dutra-Filho, M. Wajner, C. R. Vargas

Published in: Metabolic Brain Disease | Issue 4/2006

Login to get access

Abstract

Phenylketonuria (PKU) is the most frequent disturbance of amino acid metabolism being caused by severe deficiency of phenylalanine hydroxylase activity. Untreated PKU patients present severe mental retardation whose pathophysiology is not completely estabilished. Despite the low-Phe diet, a considerable number of phenylketonuric patients present a mild to moderate psychomotor delay and decreased cognitive functions. In the present study we evaluated various parameters of oxidative stress namely thiobarbituric acid-reactive species (TBA-RS), total antioxidant reactivity (TAR) and activities of the antioxidant enzymes catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px) in two groups of treated PKU patients, one with well controlled and the other with high Phe blood levels in order to investigate whether blood Phe concentrations could be correlated with the extend of oxidative stress. We initially verified a marked increase of TBA-RS, and a decrease of TAR in plasma, as well as a reduction of erythrocyte GSH-Px activity which were similar in both groups of PKU patients, when compared to controls of similar ages. In contrast, CAT and SOD activities were not altered in PKU patients. These results show that oxidative stress occurs in PKU patients and that this pathogenic process is probably not directly correlated to Phe blood levels.
Literature
go back to reference Artuch R, Colome C, Sierra C, Brandi N, Lambruschini N, Campistol J, Ugarte D, Vilaseca MA (2004) A longitudinal study of antioxidant status in phenylketonuric patients. Clin Biochem 37:198–203PubMedCrossRef Artuch R, Colome C, Sierra C, Brandi N, Lambruschini N, Campistol J, Ugarte D, Vilaseca MA (2004) A longitudinal study of antioxidant status in phenylketonuric patients. Clin Biochem 37:198–203PubMedCrossRef
go back to reference Bauman ML, Kemper TL (1982) Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria. Acta Neuropathol 58:55–63PubMedCrossRef Bauman ML, Kemper TL (1982) Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria. Acta Neuropathol 58:55–63PubMedCrossRef
go back to reference Burgard P (2000) Development of intelligence in early treated phenylketonuria. Eur J Pediatr 159:74–79CrossRef Burgard P (2000) Development of intelligence in early treated phenylketonuria. Eur J Pediatr 159:74–79CrossRef
go back to reference Colome C, Sierra C, Vilaseca MA (2000) Congenital errors of metabolism: cause of oxidative stress? Med Clin 115:111–117 Colome C, Sierra C, Vilaseca MA (2000) Congenital errors of metabolism: cause of oxidative stress? Med Clin 115:111–117
go back to reference Darling G, Mathias P, O’Regan M, Naughten E (1992) Serum selenium levels in individuals on PKU diets. J Inherit Metab Dis 15:769–773PubMedCrossRef Darling G, Mathias P, O’Regan M, Naughten E (1992) Serum selenium levels in individuals on PKU diets. J Inherit Metab Dis 15:769–773PubMedCrossRef
go back to reference Ercal N, Aykin-Burns N, Gurer-Orhan H, Mcdonald JD (2002) Oxidative stress in a phenylketonuria animal model. Free Rad Biol Med 32:906–911PubMedCrossRef Ercal N, Aykin-Burns N, Gurer-Orhan H, Mcdonald JD (2002) Oxidative stress in a phenylketonuria animal model. Free Rad Biol Med 32:906–911PubMedCrossRef
go back to reference Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Meth Enzymol 186:407–421PubMed Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Meth Enzymol 186:407–421PubMed
go back to reference Hagen MEK, Pederzolli CD, Sgaravatti AM, Bridi R, Wajner M, Wanmacher CMD, Wyse ATS, Dutra-Filho CS (2002) Experimental hyperphenylalaninemia provokes oxidative stress in rat brain. Biochim Biophys Acta 1586:344–352 Hagen MEK, Pederzolli CD, Sgaravatti AM, Bridi R, Wajner M, Wanmacher CMD, Wyse ATS, Dutra-Filho CS (2002) Experimental hyperphenylalaninemia provokes oxidative stress in rat brain. Biochim Biophys Acta 1586:344–352
go back to reference Halliwell B, Gutteridge JMC (1985) Oxygen radicals and nervous system. Trends Neurosci 8:22–26CrossRef Halliwell B, Gutteridge JMC (1985) Oxygen radicals and nervous system. Trends Neurosci 8:22–26CrossRef
go back to reference Halliwell B (1996) Free radicals, proteins and DNA: oxidative damage versus redox regulation. Biochem Soc Trans 24:1023–1027PubMed Halliwell B (1996) Free radicals, proteins and DNA: oxidative damage versus redox regulation. Biochem Soc Trans 24:1023–1027PubMed
go back to reference Halliwel B, Gutteridge JMC (2001) Oxidative stress: adaptation, damage, repair and death. In: Halliwell B, Gutteridge JMC (eds) Free radicals in biology and medicine. Oxford University Press, Oxford, pp 246–350 Halliwel B, Gutteridge JMC (2001) Oxidative stress: adaptation, damage, repair and death. In: Halliwell B, Gutteridge JMC (eds) Free radicals in biology and medicine. Oxford University Press, Oxford, pp 246–350
go back to reference Halliwell B, Whiteman M (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: How should you do it and what do the results mean? Br J Pharmacol 142:231–255PubMedCrossRef Halliwell B, Whiteman M (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: How should you do it and what do the results mean? Br J Pharmacol 142:231–255PubMedCrossRef
go back to reference Hanley WB, Lee AW, Hanley AJG, Lehotay DC, Austin VJ, Schoonheyt WE, Platt BA, Clarke JTR (2000) Hypotyrosinemia in phenylketonuria. Mol Gen Metab 69:286–394CrossRef Hanley WB, Lee AW, Hanley AJG, Lehotay DC, Austin VJ, Schoonheyt WE, Platt BA, Clarke JTR (2000) Hypotyrosinemia in phenylketonuria. Mol Gen Metab 69:286–394CrossRef
go back to reference Hendriksz CJ, Walter JH (2004) Update on phenylketonuria. Curr Paediatr 14:400–406CrossRef Hendriksz CJ, Walter JH (2004) Update on phenylketonuria. Curr Paediatr 14:400–406CrossRef
go back to reference Lissi E, Pascual C, Del Castillo MD (1992) Luminol luminescence induced by 2,2′-azo-bis-(amidinopropane) thermolysis. Free Rac Res Commun 17:299–311 Lissi E, Pascual C, Del Castillo MD (1992) Luminol luminescence induced by 2,2′-azo-bis-(amidinopropane) thermolysis. Free Rac Res Commun 17:299–311
go back to reference Lissi E, Salim-Hanna M, Pascual C, Del Castillo MD (1995). Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Rad Biol Med 18:153–158PubMedCrossRef Lissi E, Salim-Hanna M, Pascual C, Del Castillo MD (1995). Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Rad Biol Med 18:153–158PubMedCrossRef
go back to reference Lombeck I, Jochum F, Terwolbeck K (1996) Selenium status in infants and children with phenylketonuria and in maternal phenylketonuria. Eur J Pediatr 155:140–144CrossRef Lombeck I, Jochum F, Terwolbeck K (1996) Selenium status in infants and children with phenylketonuria and in maternal phenylketonuria. Eur J Pediatr 155:140–144CrossRef
go back to reference Longhi R, Rottoli A, Vittorelli A, Zecchini G, Bonabitacola T, Bertassi F, Riva E, Giovannini M (1987) Trace elements nutriture in hyperphenylalaninemic patients: Long-term follow up study. Eur J Pediatr 146:32–37CrossRef Longhi R, Rottoli A, Vittorelli A, Zecchini G, Bonabitacola T, Bertassi F, Riva E, Giovannini M (1987) Trace elements nutriture in hyperphenylalaninemic patients: Long-term follow up study. Eur J Pediatr 146:32–37CrossRef
go back to reference Lowry OH, Rosebrough NJ, Lewis-Farr A, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed Lowry OH, Rosebrough NJ, Lewis-Farr A, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed
go back to reference Martinez-Cruz F, Pozo D, Osuna C, Espinar A, Marchante C, Guerrero JM (2002) Oxidative stress induced by phenylketonuria in the rat: prevent by melatonin, vitamin E and vitamin C. J Neurosci Res 69:550–558PubMedCrossRef Martinez-Cruz F, Pozo D, Osuna C, Espinar A, Marchante C, Guerrero JM (2002) Oxidative stress induced by phenylketonuria in the rat: prevent by melatonin, vitamin E and vitamin C. J Neurosci Res 69:550–558PubMedCrossRef
go back to reference McCaman MW, Robins E (1962) Fluorimetric method for the determination of phenylalanine in serum. J Lab Clin Med 59:885–890 McCaman MW, Robins E (1962) Fluorimetric method for the determination of phenylalanine in serum. J Lab Clin Med 59:885–890
go back to reference Paglia DE, Valentine WN (1967) Glutathione peroxidase. J Lab Clin Med 70:158PubMed Paglia DE, Valentine WN (1967) Glutathione peroxidase. J Lab Clin Med 70:158PubMed
go back to reference Przyrembel H, Bremer HJ (2000) Nutrition, physical growth, and bone density in treated phenylketonuria. Eur J Pediatr 159:129–135CrossRef Przyrembel H, Bremer HJ (2000) Nutrition, physical growth, and bone density in treated phenylketonuria. Eur J Pediatr 159:129–135CrossRef
go back to reference Reznick AZ, Packer L (1993) Free radicals and antioxidants in muscular neurological diseases and disorders. In: Poli G, Albano E, Dianzani MU (eds) Free radicals: From basic science to medicine. Birkhauser, Basel, pp 425–437 Reznick AZ, Packer L (1993) Free radicals and antioxidants in muscular neurological diseases and disorders. In: Poli G, Albano E, Dianzani MU (eds) Free radicals: From basic science to medicine. Birkhauser, Basel, pp 425–437
go back to reference Rottoli A, Lista G, Zecchini G, Butté C, Longhi R (1985) Plasma selenium levels in treated phenylketonuric patients. J Inherit Metab Dis 8:127–128PubMedCrossRef Rottoli A, Lista G, Zecchini G, Butté C, Longhi R (1985) Plasma selenium levels in treated phenylketonuric patients. J Inherit Metab Dis 8:127–128PubMedCrossRef
go back to reference Schulpis KH, Tsakiris S, Karikas GA, Moukas M, Behrakis P (2003) Effect of diet on plasma total antioxidant status in phenylketonuric patients. Eur J Clin Nutr 57:282–287CrossRef Schulpis KH, Tsakiris S, Karikas GA, Moukas M, Behrakis P (2003) Effect of diet on plasma total antioxidant status in phenylketonuric patients. Eur J Clin Nutr 57:282–287CrossRef
go back to reference Schulpis KH, Tsakiris S, Traeger-Synodinos J, Papassotiriou I (2005) Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria. Clin Biochem 38:239–242PubMedCrossRef Schulpis KH, Tsakiris S, Traeger-Synodinos J, Papassotiriou I (2005) Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria. Clin Biochem 38:239–242PubMedCrossRef
go back to reference Schulz JB, Lindenau J, Seyfried J, Dichgans J (2000) Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267:4904–4911PubMedCrossRef Schulz JB, Lindenau J, Seyfried J, Dichgans J (2000) Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267:4904–4911PubMedCrossRef
go back to reference Scriver CR, Kaufmann S (2001) The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease, 8th edn. McGraw-Hill, New York, pp 1667–1724 Scriver CR, Kaufmann S (2001) The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease, 8th edn. McGraw-Hill, New York, pp 1667–1724
go back to reference Shefer S, Tint GS, Jean-Guillaume D, Daikhin E, Kendler A, Nguyen LB, Yudkoff M, Charissa A, Dyer CA (2000) Is there a relationship between 3-hydroxy-3-methylglutaryl Coenzyme A reductase activity and forebrain pathology in the PKU mouse? J Neurosci Res 61:549–563PubMedCrossRef Shefer S, Tint GS, Jean-Guillaume D, Daikhin E, Kendler A, Nguyen LB, Yudkoff M, Charissa A, Dyer CA (2000) Is there a relationship between 3-hydroxy-3-methylglutaryl Coenzyme A reductase activity and forebrain pathology in the PKU mouse? J Neurosci Res 61:549–563PubMedCrossRef
go back to reference Sierra C, Vilaseca MA, Moyano D, Brandi N, Campistol J, Lambruschini N, Cambra FJ, Deulofeu R, Mira A (1998) Antioxidant status in hyperphenylalaninemia. Clin Chim Acta 276:1–9PubMedCrossRef Sierra C, Vilaseca MA, Moyano D, Brandi N, Campistol J, Lambruschini N, Cambra FJ, Deulofeu R, Mira A (1998) Antioxidant status in hyperphenylalaninemia. Clin Chim Acta 276:1–9PubMedCrossRef
go back to reference Sirtori LR, Dutra-Filho CS, Fitarelli D, Sitta A, Haeser A, Barschak AG, Wajner M, Coelho DM, Llesuy S, Belló-Klein A, Giugliani R, Deon M, Vargas CR (2005) Oxidative stress in patients with phenylketonuria. Biochim Biophys Acta 1740:68–73PubMed Sirtori LR, Dutra-Filho CS, Fitarelli D, Sitta A, Haeser A, Barschak AG, Wajner M, Coelho DM, Llesuy S, Belló-Klein A, Giugliani R, Deon M, Vargas CR (2005) Oxidative stress in patients with phenylketonuria. Biochim Biophys Acta 1740:68–73PubMed
go back to reference van Backel MM, Printzen G, Wermuth B, Wiesmann UN (2000) Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients. Am J Clin Nutr 72:976–981 van Backel MM, Printzen G, Wermuth B, Wiesmann UN (2000) Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients. Am J Clin Nutr 72:976–981
go back to reference Wajner M, Latini A, Wyse AT, Dutra-Filho CS (2004) The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis 27:427–448PubMedCrossRef Wajner M, Latini A, Wyse AT, Dutra-Filho CS (2004) The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis 27:427–448PubMedCrossRef
go back to reference Weglage J, Pietsch M, Funders B, Koch HG, Ullrich K (1995) Neurological findings in early treated phenylketonuria. Acta Paediatr 84:411–415PubMed Weglage J, Pietsch M, Funders B, Koch HG, Ullrich K (1995) Neurological findings in early treated phenylketonuria. Acta Paediatr 84:411–415PubMed
go back to reference Wyse ATS, Sarkis JJ, Cunha-Filho JS, Teixeira MV, Schetinger MR, Wajner M, Milton C, Wannmacher C (1994) Effect of phenylalanine and its metabolites on ATP diphosphohydrolase activity in synaptosomes from rat cerebral cortex. Neurochem Res 19:1175–1180PubMedCrossRef Wyse ATS, Sarkis JJ, Cunha-Filho JS, Teixeira MV, Schetinger MR, Wajner M, Milton C, Wannmacher C (1994) Effect of phenylalanine and its metabolites on ATP diphosphohydrolase activity in synaptosomes from rat cerebral cortex. Neurochem Res 19:1175–1180PubMedCrossRef
Metadata
Title
Investigation of oxidative stress parameters in treated phenylketonuric patients
Authors
A. Sitta
A. G. Barschak
M. Deon
T. Terroso
R. Pires
R. Giugliani
C. S. Dutra-Filho
M. Wajner
C. R. Vargas
Publication date
01-12-2006
Published in
Metabolic Brain Disease / Issue 4/2006
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-006-9035-0

Other articles of this Issue 4/2006

Metabolic Brain Disease 4/2006 Go to the issue